<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Psychology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4E80443A-E7AA-4216-9492-FC8B1A583B53"><gtr:id>4E80443A-E7AA-4216-9492-FC8B1A583B53</gtr:id><gtr:firstName>Trevor</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Robbins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C483069-8D3A-498D-8435-56F37F66DEBB"><gtr:id>6C483069-8D3A-498D-8435-56F37F66DEBB</gtr:id><gtr:firstName>Jean-Claude</gtr:firstName><gtr:surname>Baron</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FB718CC2-60A9-424C-874E-006BC98FFF1E"><gtr:id>FB718CC2-60A9-424C-874E-006BC98FFF1E</gtr:id><gtr:firstName>Jeffrey</gtr:firstName><gtr:otherNames>Wayne</gtr:otherNames><gtr:surname>Dalley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1C1CBC4C-9A53-47AC-A87F-1C8599099F6B"><gtr:id>1C1CBC4C-9A53-47AC-A87F-1C8599099F6B</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Fryer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5638B83E-8513-4CEC-A4BD-0C0805F4A22C"><gtr:id>5638B83E-8513-4CEC-A4BD-0C0805F4A22C</gtr:id><gtr:firstName>Franklin</gtr:firstName><gtr:otherNames>Imo</gtr:otherNames><gtr:surname>Aigbirhio</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4E48C463-C4A9-4E59-9610-26BF3B635A7D"><gtr:id>4E48C463-C4A9-4E59-9610-26BF3B635A7D</gtr:id><gtr:firstName>Barry</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Everitt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701500"><gtr:id>7D843BE3-8F4A-48FC-813B-3DA258CC79E9</gtr:id><gtr:title>Neurobiological correlates of trait impulsivity and drug abuse vulnerability</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701500</gtr:grantReference><gtr:abstractText>It is becoming increasingly recognised that many people in society can apparently use drugs such as cocaine for prolonged periods of time without ever becoming dependent on the drug. For example, it has been estimated that less than 20% of people who use cocaine actually become addicted; or in other words, show an escalating pattern of drug consumption, a persistence of drug taking despite adverse consequences (e.g., marital and family breakdown, unemployment, ill health and the threat of incarceration) and ultimately a loss of control over drug intake. Recent research also indicates that certain personality traits (e.g., sensation- and novelty-seekers), as well as people diagnosed with attention-deficit hyperactivity disorder (ADHD), depression and other brain disorders, are more likely to abuse drugs and progress ultimately to the advanced stages of drug addiction. This research focuses on underlying abnormalities in brain chemistry associated with certain personality traits and investigates how these changes confer vulnerability for drug abuse and addiction. A powerful non-invasive brain imaging technique will be used (positron emission tomography or ?PET?) to visualise a particular chemical receptor in the brain which previous research has linked to certain impulsive traits (i.e., behaviour that is poorly planned and controlled and occurs without due consideration or foresight), as well as the long-term effects of cocaine and other drugs of abuse on the brain. Our specific objective is to elucidate the brain mechanisms associated with the increased risk for cocaine addiction of individuals showing high levels of impulsive behaviour ? a core symptom of ADHD ?and thereby address why these individuals are more likely to become addicted to cocaine and other drugs of abuse. A key to this research is that we are able to assess in the same individual the progression from first drug exposure to the emergence of drug addictive behaviour, thereby determining changes in brain chemistry that potentially underlie the transition from recreational drug use to repeated use and addiction. This research has important implications for understanding the neurobiology of, and inter-relationship between, ADHD and drug addiction and thus in discovering new ways of treating these debilitating and frequently co-morbid brain disorders. It also addresses the contentious issue whether the ?paradoxical? treatment of ADHD with stimulant drugs such as methylphenidate (or Ritalin?) alters the progression from casual to compulsive drug use, thereby enabling the development of novel therapies.</gtr:abstractText><gtr:technicalSummary>Despite the complexity of the problem, the costs to the UK economy and healthcare system of chronic drug abuse and addiction are too enormous to ignore. Notwithstanding intensive research efforts we still do not understand why some individuals use or become dependent on drugs nor do we have effective treatments to prevent or ameliorate this pervasive and devastating brain disorder. However, an important clue to the aetiology of drug addiction is that it tends to be linked to certain personality traits (e.g., risk-takers, sensation- or novelty-seekers), and people diagnosed with certain brain disorders (e.g., depression and attention-deficit hyperactivity disorder or ADHD). However, from studies of human drug addicts alone, it is difficult to resolve whether cognitive dysfunction and co-morbid disorders pre-date the onset of drug use or emerge as a consequence of chronic drug exposure. It is also unclear how personality traits linked to risk taking and impulsivity confer vulnerability to addiction. A prominent theory in recent years is that the transition from voluntary to habitual and compulsive drug use reflects a progression from ventral to more dorsal regions of the striatum. This research tests the hypothesis that the emergence of addiction (or compulsive drug seeking) is accentuated by pre-existing abnormalities in dopamine function in the ventral striatum of subjects exhibiting spontaneously high levels of impulsivity, leading to a loss of control over drug intake and a progressive disruption of DA function in the dorsal striatum. Our specific research plan is to use positron emission tomography (PET) to assess longitudinally changes in DA D2/3 receptor availability (inferred by [18F]fallypride binding) in the ventral and dorsal striatum prior to, and following, extended exposure of low and high impulsive subjects to cocaine. We also aim to investigate whether the transition to compulsive cocaine use ? defined by the persistence of responding for drug under punishment ? can be attenuated or even blocked by treatment with drugs with proven or putative efficacy in ADHD. This research is fundamentally important because it examines for the first time the neurobiology of drug addiction vulnerability and the processes underlying the transition from first drug use to repeated use and addiction. This research also allows direct translation to analogous imaging studies in human drug addicts and ADHD patients, thereby facilitating the discovery of novel brain mechanisms relevant to the aetiology and treatment of these debilitating and often co-morbid brain disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>967458</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited lecture (Amsterdam)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64EBBACA-D555-44F3-8030-7404C56CE3A9</gtr:id><gtr:impact>Plenary talk - VUMC, Amsterdam. 200+ people (Faculty, post-docs, graduates). March 13th. &amp;quot;Jumping the gun: novel brain mechanisms and markers&amp;quot;

Strengthened collaborative links between Cambridge and the VUMC in Amsterdam</gtr:impact><gtr:outcomeId>e1ucWtm7ZbF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIDA-sponsored Addiction Workshop, Barcelona</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3F174D83-FF84-4E83-8F93-26152B3675A0</gtr:id><gtr:impact>Long discussion and many questions

A podcast of the talk/workshop is available on YouTube.</gtr:impact><gtr:outcomeId>5460f829bd2797.97397554</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture (Munich)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3D5CD18E-FF9A-4687-98ED-E4785CFD192B</gtr:id><gtr:impact>Plenary talk, Max Plank Institute of Psychiatry, Munich. &amp;quot;The neuroscience of impulse control: novel biomarkers and mechanisms&amp;quot;. 250+.

Scientific networking and collaboration</gtr:impact><gtr:outcomeId>sMG17eLhuW1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BAP workshop (Nottingham)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77F7DF9D-D962-4DE2-86A5-DB99BDAD2049</gtr:id><gtr:impact>20 postgraduate students attended this BAP-organised workshop (Psychopharmacology Preclinical Certificate). Talk title: MicroPET and fMRI: what can they tell us with behavioural techniques&amp;quot;

N/A</gtr:impact><gtr:outcomeId>ggHqADufL9w</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium talk (Palm Springs)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E2F3A505-13D5-4545-A4FA-09C492346707</gtr:id><gtr:impact>~500 participanats. Annual International Meeting of the College on Problems of Drug Dependence (CPDD), Palm Springs, USA, June 11th

Established new collaborations</gtr:impact><gtr:outcomeId>gyRRiCZYSVy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on publishing (FENS, Milan)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E32EC59E-289A-48C9-9922-F758B7BF9D25</gtr:id><gtr:impact>The workshop generated a lively discussion on how to successfully publish research findings

May have encouraged post-docs to submit their articles to EJN</gtr:impact><gtr:outcomeId>5460f6077c5c70.69856956</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium (USA)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ABE5EBE9-2E13-4AB1-94F6-EAA07C300765</gtr:id><gtr:impact>~500 in attendence. Annual Meeting of the Biological Psychiatry Society, San Francisco, May 10th.
&amp;quot;Addiction biomarkers: translational approaches toward identifying risk and novel treatments&amp;quot;

Established a consultancy collaboration with Boehringer Ingelheim Pharma GmbH.</gtr:impact><gtr:outcomeId>nNdED5PwfxY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk (Cambridge)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>14CA15DA-A2BD-4EAB-80BA-D059C7F49081</gtr:id><gtr:impact>Cambridge Psychopharmacology Programme, Master Class: Latest Advances in Psychopharmacology, Cambridge, April 18-20th. Organised by Stephen Stahl. 500+. Talk title: &amp;quot;Brain circuits and addiction: substrates for potential new treatments for addiction&amp;quot;

Established several collaborations</gtr:impact><gtr:outcomeId>DCpqZ5u77sm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sciscreen public lecture (Cambridge)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E160803B-AD8B-4D22-8461-82508D483FB5</gtr:id><gtr:impact>100 people attended my talk on the brain science of addiction, which preceeded the movie &amp;quot;Trainspotting&amp;quot;. Many questions were asked during an informal Q&amp;amp;A session after the movie.

Follow-up questions from the public (via email)</gtr:impact><gtr:outcomeId>EWxGzHao713</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary talk (Ireland)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0BFB3C95-C422-477E-B081-A9D2FBFEBD99</gtr:id><gtr:impact>Annual Symposium, Institute of Neuroscience, Trinity College Dublin

Invited speakers participated in a Q&amp;amp;A session with doctoral and post-doctoral workers to discuss career options and current issues/hot topics in neuroscience.</gtr:impact><gtr:outcomeId>VbvtH2NHp9N</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium (Russia)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E1C3ADB2-4AC7-43C1-BA8F-BB0B84496C66</gtr:id><gtr:impact>~400 in attendence. European College of Neuropsychopharmacology, St Petersburg, Russia, April 14th.
&amp;quot;Inter-individual differences in impulsivity and underlying neurobiology&amp;quot;

Established a potential collaboration with the Max Planck Institute in Germany</gtr:impact><gtr:outcomeId>N25x2FH6bvb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium (Holland)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1E3FD568-3731-4F8E-8442-8833B1BCA44B</gtr:id><gtr:impact>~500 in attendence. International Symposium on PET and SPECT in Neurology and Psychiatry, Groningen

Invited manuscript to be published in 2013
&amp;quot;PET and SPECT in Psychiatry&amp;quot; Springer Verlag
(Berlin-Heidelberg-New York).</gtr:impact><gtr:outcomeId>fhLXUP5YjJa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BAP Residential Course, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DB796D3D-E84F-4208-AE86-D7B2AB625FEF</gtr:id><gtr:impact>Lively and lengthy discussion. Attendees were able to visit an imaging facility

Difficult to assess beyond attendees receiving credits for the BAP training course.</gtr:impact><gtr:outcomeId>5460f77a91d823.67653050</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DC5FD859-3357-46E4-B1EE-90EE2F6FB312</gtr:id><gtr:impact>500+ attended. Lively discussion followed - moved to another location as questions continued for ~1 hour.

Notable interest of the public to learn about OCD, addiction and eating disoders</gtr:impact><gtr:outcomeId>ME2mmoFdJGi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture tour - New Zealand</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B200D043-12AC-458E-88C1-8DA5E72D8C4B</gtr:id><gtr:impact>Gave several public letures during 'brain awareness' week in New Zealand (March 2009). Visited a number of schools and discussed current topics in brain research. Visited drug rehabilitation units and hospital clinics.

Gave 5 radio interviews, including one to Radio New Zealand</gtr:impact><gtr:outcomeId>F3578C0DB10</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2703298</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme grant</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A47B56B2-7B2F-4A10-927D-7FB2BE30C033</gtr:id><gtr:outcomeId>KmcCT5ybt2n0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1780856</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>46C4B518-52B2-4AF1-B1D3-3BD2ADCA8135</gtr:id><gtr:outcomeId>fk5GwxQX2pZ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of 18F-altanserin, a selective 5-HT2A receptor agonist for PET imaging in small animals</gtr:description><gtr:id>6D7F2D6B-14AF-4FB2-93D4-13DEE27CA497</gtr:id><gtr:impact>Riss PJ, Hong YT, Williamson D, Caprioli D, Sitnikov S, Ferrari V, Sawiak SJ, Baron J-C, Dalley JW, Fryer TD and Aigbirhio (2011) Quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling. J. Cerebral Blood Flow and Metabolism 31: 2334-2342.</gtr:impact><gtr:outcomeId>QsMVNFHXQ1b</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of 18F-altanserin</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A novel mu-opioid receptor ligand for PET imaging in small animals</gtr:description><gtr:id>2B17B892-1CB3-4C5C-BDE0-094C0FC8C573</gtr:id><gtr:impact>Riss PJ, Hong YT, Marton J, Caprioli D, Williamson DJ, Ferrari V, Saigal N, Roth B, Henriksen G, Fryer TD, Dalley JW, Aigbirhio FI (2012) Synthesis and evaluation of (20R)-4,5-epoxy-17-methyl-3-hydroxy-6-(2-[18F]fluoroethoxy)-,17- dimethyl-a-(2-phenyleth-1-yl)-6,14-etheneomorphinan-7-methanol in rodents: an 18F-labelled full agonist for opioid receptor imaging. J. Nuclear Medicine (in press).</gtr:impact><gtr:outcomeId>BqSL9axMeqX</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Development of FEPEO</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1A4D73A1-7FE8-4F48-BE93-B778DF9A2FF3</gtr:id><gtr:title>Social dominance in rats: effects on cocaine self-administration, novelty reactivity and dopamine receptor binding and content in the striatum.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543052f863c29b815882f914d3701d60"><gtr:id>543052f863c29b815882f914d3701d60</gtr:id><gtr:otherNames>Jupp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>56d84e28bceaa2.38623635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D47FCE3-06B7-4DB5-B7A0-CEF79D33FF59</gtr:id><gtr:title>High anxiety is a predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c178da1448edc3f9343bcdeef76e521a"><gtr:id>c178da1448edc3f9343bcdeef76e521a</gtr:id><gtr:otherNames>Dilleen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_14861_21_22245944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>358D3D9C-1716-4A9F-B29D-1AB1A888CD8D</gtr:id><gtr:title>Increased impulsivity retards the transition to dorsolateral striatal dopamine control of cocaine seeking.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6892d496fb7cfc02f1e5c03661cddd5"><gtr:id>e6892d496fb7cfc02f1e5c03661cddd5</gtr:id><gtr:otherNames>Murray JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_14861_21_24157338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3AE2ECC-B694-44E5-800B-2F7019349481</gtr:id><gtr:title>Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543052f863c29b815882f914d3701d60"><gtr:id>543052f863c29b815882f914d3701d60</gtr:id><gtr:otherNames>Jupp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5460d19d3c96d2.26882898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8934703F-4112-4BFD-9AB0-5DA30E0DD255</gtr:id><gtr:title>In search of predictive endophenotypes in addiction: insights from preclinical research.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ceb839e05a529dc2fbb7eeb4725503fe"><gtr:id>ceb839e05a529dc2fbb7eeb4725503fe</gtr:id><gtr:otherNames>Belin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>56d84e28893713.05003084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA3494AF-DAC4-47C4-ADCB-D50115778C2F</gtr:id><gtr:title>Gamma aminobutyric acidergic and neuronal structural markers in the nucleus accumbens core underlie trait-like impulsive behavior.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a204b8a3d47fba451af19560ec2abf6"><gtr:id>1a204b8a3d47fba451af19560ec2abf6</gtr:id><gtr:otherNames>Caprioli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_14861_21_23973096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBECE373-C39C-4E56-B685-A7159A83867A</gtr:id><gtr:title>Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/963612784fd5db47dc3eed2db9c91b55"><gtr:id>963612784fd5db47dc3eed2db9c91b55</gtr:id><gtr:otherNames>Voon V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>aD1da2oCosK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CBABC10-373B-45E1-8C07-5EEC561F16C6</gtr:id><gtr:title>Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e54267197bb12fcd981028a1a58b88"><gtr:id>12e54267197bb12fcd981028a1a58b88</gtr:id><gtr:otherNames>Isherwood SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>5675e647c9f48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31B055B7-0BED-44D8-A69C-9A19ABF94C7D</gtr:id><gtr:title>N-acetylcysteine Facilitates Self-Imposed Abstinence After Escalation of Cocaine Intake.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03c2c1d879634057003b41a0919b8335"><gtr:id>03c2c1d879634057003b41a0919b8335</gtr:id><gtr:otherNames>Ducret E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>585d671e765629.34550349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA493146-101F-4DFE-B8B9-01B159B4CFBD</gtr:id><gtr:title>Oscillatory activity in the medial prefrontal cortex and nucleus accumbens correlates with impulsivity and reward outcome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7426cecbeeb00c817e545dd023df8213"><gtr:id>7426cecbeeb00c817e545dd023df8213</gtr:id><gtr:otherNames>Donnelly NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460d19d66df88.94280339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA290CB7-4E04-4645-B9FD-C7D9DB593B1D</gtr:id><gtr:title>High impulsivity predicting vulnerability to cocaine addiction in rats: some relationship with novelty preference but not novelty reactivity, anxiety or stress.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f68782d39c50fe3aba7d1c2236c3740"><gtr:id>5f68782d39c50fe3aba7d1c2236c3740</gtr:id><gtr:otherNames>Molander AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>kAup2tuH5Dq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>612F4CB2-A991-4857-9D29-600E9001BF18</gtr:id><gtr:title>What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cbc0cff1e5f0f4c1a5612c2cb78f67d"><gtr:id>1cbc0cff1e5f0f4c1a5612c2cb78f67d</gtr:id><gtr:otherNames>Cumming P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>p63xVmT1HTG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5426673C-7A51-4DC7-AD3B-517ECCED02C2</gtr:id><gtr:title>Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.</gtr:title><gtr:parentPublicationTitle>Neuroscience and biobehavioral reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54cbeb0a12b195b78bcf0572ae0cfe39"><gtr:id>54cbeb0a12b195b78bcf0572ae0cfe39</gtr:id><gtr:otherNames>Virdee K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0149-7634</gtr:issn><gtr:outcomeId>pm_14861_21_22342372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EF2D153-30B6-4B39-AA84-EDB50799BF23</gtr:id><gtr:title>Single chemical entity legal highs: assessing the risk for long term harm.</gtr:title><gtr:parentPublicationTitle>Current drug abuse reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b28aea1060a096702c207916ff95848"><gtr:id>9b28aea1060a096702c207916ff95848</gtr:id><gtr:otherNames>McNabb CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1874-4737</gtr:issn><gtr:outcomeId>pm_14861_21_23244343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEB08A45-8AF0-41BC-93CE-DE24194EFF18</gtr:id><gtr:title>Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d23f7b00f22d6338172fe81219fe06a7"><gtr:id>d23f7b00f22d6338172fe81219fe06a7</gtr:id><gtr:otherNames>Everitt BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>A0F2DA0E528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A504A777-252E-475A-9532-990C8953F192</gtr:id><gtr:title>Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.</gtr:title><gtr:parentPublicationTitle>The international journal of neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71645f29d1a3d704b3ad6de6c60a495e"><gtr:id>71645f29d1a3d704b3ad6de6c60a495e</gtr:id><gtr:otherNames>Barnes SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1461-1457</gtr:issn><gtr:outcomeId>doi_55f9849848c1fcf1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20E4DA3A-FBC8-45EE-986E-C14158E7D930</gtr:id><gtr:title>Dopamine, serotonin and impulsivity.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>pm_14861_21_22542672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7CB3921-5E81-4FF5-B34D-52B42A5EB907</gtr:id><gtr:title>Brain ?-aminobutyric acid: a neglected role in impulsivity.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84940c7edb7b1b867f4fa9d1f2571c32"><gtr:id>84940c7edb7b1b867f4fa9d1f2571c32</gtr:id><gtr:otherNames>Hayes DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>doi_55f985985071291d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFFD7B06-C435-4F11-AD61-3F8E1187731E</gtr:id><gtr:title>Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D2/3 receptor availability in the striatum.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a204b8a3d47fba451af19560ec2abf6"><gtr:id>1a204b8a3d47fba451af19560ec2abf6</gtr:id><gtr:otherNames>Caprioli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>doi_55f9849848d4d946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A32D2B68-93A6-456C-AA31-B30B8D586878</gtr:id><gtr:title>Trait-like impulsivity does not predict escalation of heroin self-administration in the rat.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd1816488a945de18bbc5aac73e7732d"><gtr:id>cd1816488a945de18bbc5aac73e7732d</gtr:id><gtr:otherNames>McNamara R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>QBUroAadHeF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2196452-3FEC-424B-8F3A-88ACD167BD7B</gtr:id><gtr:title>Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On.</gtr:title><gtr:parentPublicationTitle>Annual review of psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d23f7b00f22d6338172fe81219fe06a7"><gtr:id>d23f7b00f22d6338172fe81219fe06a7</gtr:id><gtr:otherNames>Everitt BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0066-4308</gtr:issn><gtr:outcomeId>585d57dd526ad4.37495984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06DEC1D9-F1ED-4C0F-96F9-B489818C1A20</gtr:id><gtr:title>Highly impulsive rats: modelling an endophenotype to determine the neurobiological, genetic and environmental mechanisms of addiction.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543052f863c29b815882f914d3701d60"><gtr:id>543052f863c29b815882f914d3701d60</gtr:id><gtr:otherNames>Jupp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>5460d19c84ff80.40667479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7BDA307-A2A3-475D-9624-16717B2506C7</gtr:id><gtr:title>Modelling human drug abuse and addiction with dedicated small animal positron emission tomography.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>5C5EC43F9B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83441E55-1CB4-4581-970F-7D964CF2DBE9</gtr:id><gtr:title>Endocannabinoids and striatal function: implications for addiction-related behaviours.</gtr:title><gtr:parentPublicationTitle>Behavioural pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44910192c587842718b955f8a092ca4"><gtr:id>d44910192c587842718b955f8a092ca4</gtr:id><gtr:otherNames>Moreira FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0955-8810</gtr:issn><gtr:outcomeId>5460d19d946f40.17580322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA5A06FB-5DBC-4248-8E9E-A6C4C9CF6954</gtr:id><gtr:title>Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543052f863c29b815882f914d3701d60"><gtr:id>543052f863c29b815882f914d3701d60</gtr:id><gtr:otherNames>Jupp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>5460d19cadd8a9.03468547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1ACA61F-CD34-4231-AE25-C04952AB6840</gtr:id><gtr:title>Linking ADHD, impulsivity, and drug abuse: a neuropsychological perspective.</gtr:title><gtr:parentPublicationTitle>Current topics in behavioral neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ce63c13ac956b6d1ac1e88e6ff8cd47"><gtr:id>2ce63c13ac956b6d1ac1e88e6ff8cd47</gtr:id><gtr:otherNames>Urcelay GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1866-3370</gtr:issn><gtr:outcomeId>NGafijdo7Dh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEE1B493-B5F1-4B35-BB10-AE1990FBA621</gtr:id><gtr:title>Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d8ee4675a2b4ea6054eddda4ee1e32"><gtr:id>d9d8ee4675a2b4ea6054eddda4ee1e32</gtr:id><gtr:otherNames>Besson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>1A42CFE172D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D29E6B82-60D5-4CBC-80B2-3FC89088FC1B</gtr:id><gtr:title>In vivo ?-aminobutyric acid measurement in rats with spectral editing at 4.7T.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8414e92014cc08e8ba0baa0ab7027d7"><gtr:id>b8414e92014cc08e8ba0baa0ab7027d7</gtr:id><gtr:otherNames>Sawiak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d84e28ede4f5.68412956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>314CF867-73FE-4033-9634-BBE937119966</gtr:id><gtr:title>Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b58bef0027183b073494e71036ddfd7"><gtr:id>5b58bef0027183b073494e71036ddfd7</gtr:id><gtr:otherNames>Economidou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_14861_21_22510726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EAB1B7B-8B20-4D1A-AF55-0626D71D3643</gtr:id><gtr:title>Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry.</gtr:title><gtr:parentPublicationTitle>Pharmacology, biochemistry, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0091-3057</gtr:issn><gtr:outcomeId>476BDAB4230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E3D8F91-AB12-4485-BA72-98B707FE7161</gtr:id><gtr:title>Addiction: failure of control over maladaptive incentive habits.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ceb839e05a529dc2fbb7eeb4725503fe"><gtr:id>ceb839e05a529dc2fbb7eeb4725503fe</gtr:id><gtr:otherNames>Belin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>doi_55f9849848ae201b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9226FB53-4CDE-40DC-90EC-86BF191E49FE</gtr:id><gtr:title>Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a204b8a3d47fba451af19560ec2abf6"><gtr:id>1a204b8a3d47fba451af19560ec2abf6</gtr:id><gtr:otherNames>Caprioli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>5460d19cdb5a07.40330489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73CF87EE-D767-4B02-8985-A77C2AD0461F</gtr:id><gtr:title>Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e54267197bb12fcd981028a1a58b88"><gtr:id>12e54267197bb12fcd981028a1a58b88</gtr:id><gtr:otherNames>Isherwood SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>5a616b36c08340.93849543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B549D8DE-D3B5-4C58-A558-29355957D92A</gtr:id><gtr:title>Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a204b8a3d47fba451af19560ec2abf6"><gtr:id>1a204b8a3d47fba451af19560ec2abf6</gtr:id><gtr:otherNames>Caprioli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>pm_14861_21_23664005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>998DA66A-54CE-49BF-A537-EE9469AD0250</gtr:id><gtr:title>Divergent effects of D2/3 receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8caf0edf96a5694fad5529079c22e98a"><gtr:id>8caf0edf96a5694fad5529079c22e98a</gtr:id><gtr:otherNames>Moreno M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>5460d19d134eb6.84759611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF42F0F-71F6-42E8-AA52-49E0412CE7CE</gtr:id><gtr:title>Fractionating impulsivity: neuropsychiatric implications.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>5a6d9bb8d19dd2.51176842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9A3E7CB-1349-43E4-B3F9-A1F5448CBC29</gtr:id><gtr:title>Dopamine receptors in the learning, memory and drug reward circuitry.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>37F70DF93AF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA9C7C45-939D-4E5F-B113-ADCD14CDEB17</gtr:id><gtr:title>Synthesis and evaluation of 18F-FE-PEO in rodents: an 18F-labeled full agonist for opioid receptor imaging.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f97b77c7d2fd486349ce8c01bd73e8b"><gtr:id>9f97b77c7d2fd486349ce8c01bd73e8b</gtr:id><gtr:otherNames>Riss PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>pm_14861_21_23297076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58BAE4B1-E2FF-4A2D-AEFA-E47FB9393D1B</gtr:id><gtr:title>Impulsivity, compulsivity, and top-down cognitive control.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8452d1ca598e0a6ded89a8d11e5406f4"><gtr:id>8452d1ca598e0a6ded89a8d11e5406f4</gtr:id><gtr:otherNames>Dalley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>UPpyDdxVnUg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E59A3D-FFCC-47B9-BF56-09C4E267C372</gtr:id><gtr:title>Markers of serotonergic function in the orbitofrontal cortex and dorsal raph&amp;eacute; nucleus predict individual variation in spatial-discrimination serial reversal learning.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a34bf5bae2139b2637e0a5f8ccbfeab2"><gtr:id>a34bf5bae2139b2637e0a5f8ccbfeab2</gtr:id><gtr:otherNames>Barlow RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>5675de5ce42e2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6B19C1A-13CE-408D-9735-76F16AFC7264</gtr:id><gtr:title>Behavioral endophenotypes of drug addiction: Etiological insights from neuroimaging studies.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543052f863c29b815882f914d3701d60"><gtr:id>543052f863c29b815882f914d3701d60</gtr:id><gtr:otherNames>Jupp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>pm_14861_21_23756169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87EFB798-21FD-4666-9C8B-DEF567F6AF0A</gtr:id><gtr:title>Cocaine modulation of frontostriatal expression of Zif268, D2, and 5-HT2c receptors in high and low impulsive rats.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d8ee4675a2b4ea6054eddda4ee1e32"><gtr:id>d9d8ee4675a2b4ea6054eddda4ee1e32</gtr:id><gtr:otherNames>Besson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_14861_21_23632436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F50D31D9-65A8-4218-8F16-C80BD8C10BBF</gtr:id><gtr:title>Measuring &amp;quot;waiting&amp;quot; impulsivity in substance addictions and binge eating disorder in a novel analogue of rodent serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/963612784fd5db47dc3eed2db9c91b55"><gtr:id>963612784fd5db47dc3eed2db9c91b55</gtr:id><gtr:otherNames>Voon V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_14861_21_23790224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31D44939-6B7F-49B3-B610-593F01800DE9</gtr:id><gtr:title>Dopamine receptor partial agonists and addiction.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d44910192c587842718b955f8a092ca4"><gtr:id>d44910192c587842718b955f8a092ca4</gtr:id><gtr:otherNames>Moreira FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>doi_55f9849848b86131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A03ACA9A-A551-4EF5-9711-0038E0E82607</gtr:id><gtr:title>Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28130acf6e72450a7b88abcb8c2aa64c"><gtr:id>28130acf6e72450a7b88abcb8c2aa64c</gtr:id><gtr:otherNames>Fernando AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>szv3mcJNr7t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75DBE8A9-630E-49B4-BC2E-21F356F6D2C9</gtr:id><gtr:title>Ramping single unit activity in the medial prefrontal cortex and ventral striatum reflects the onset of waiting but not imminent impulsive actions.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7426cecbeeb00c817e545dd023df8213"><gtr:id>7426cecbeeb00c817e545dd023df8213</gtr:id><gtr:otherNames>Donnelly NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>5675e2c6b1998</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701500</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>